{"transactions":[{"id":720682,"issuer":{"id":1933,"kind":"organization","name":"Autolus Therapeutics plc","symbol":"AUTL"},"owners":[{"id":33771,"kind":"person","name":"Leiderman Elisabeth","position":1,"cik":"0001842133","reported_name":"Leiderman Elisabeth","relationship":{"director":true}}],"security":"Share Option (Right to Buy)","published_at":"2026-07-01T20:15:21.000Z","date":"2026-06-29","kind":"grant","planned":false,"acquired":true,"shares":47500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Share options vest in twelve equal monthly installments commencing on July 29, 2026."}],"balance_after":47500,"derivative":{"exercise_price":1.61,"expiration_date":"2036-06-29","underlying":"American Depositary Shares","underlying_shares":47500},"source":{"system":"sec-edgar","filing":"0001730463-26-000101","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730463/000173046326000101/form4.xml","form_type":"4"}},{"id":720681,"issuer":{"id":1933,"kind":"organization","name":"Autolus Therapeutics plc","symbol":"AUTL"},"owners":[{"id":33771,"kind":"person","name":"Leiderman Elisabeth","position":1,"cik":"0001842133","reported_name":"Leiderman Elisabeth","relationship":{"director":true}}],"security":"Restricted Share Units","published_at":"2026-07-01T20:15:21.000Z","date":"2026-06-29","kind":"grant","planned":false,"acquired":true,"shares":31667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's American Depositary Shares. Each American Depositary Share is convertible at any time at the option of the Reporting Person into one Ordinary Share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in one installment on June 29, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in one installment on June 29, 2027."}],"balance_after":31667,"derivative":{"underlying":"American Depositary Shares","underlying_shares":31667},"source":{"system":"sec-edgar","filing":"0001730463-26-000101","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730463/000173046326000101/form4.xml","form_type":"4"}},{"id":1124573,"issuer":{"id":78923,"kind":"organization","name":"bluebird bio, Inc.","symbol":"BLUE"},"owners":[{"id":33771,"kind":"person","name":"Leiderman Elisabeth","position":1,"cik":"0001842133","reported_name":"Leiderman Elisabeth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-03T17:29:38.000Z","date":"2025-06-02","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1245,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each time-based restricted stock unit award with respect to shares that is, at the time of determination, subject to vesting or forfeiture conditions and that is not a PSU Award (as defined below) (but including, for clarity, any PSU Award that is subject solely to service-based vesting conditions as of the Effective Time) (\"RSU Award\") that is outstanding as of immediately prior thereto, shall (a) accelerate and become fully vested, and (b) by virtue of the Merger automatically (except as otherwise provided in the Merger Agreement) and without any action on the part of the Issuer, Parent or the holder thereof, be canceled and terminated and converted into the right to receive"},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(Continued from footnote 3) (i) an amount in cash equal to the product of the number of shares underlying such RSU Award immediately prior to the Effective Time and $3.00 in cash, subject to any applicable withholding taxes and without interest thereon plus (ii) one CVR with respect to each share subject to such RSU Award immediately prior to the Effective Time."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-25-081135","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1293971/000095017025081135/ownership.xml","form_type":"4"}},{"id":1124572,"issuer":{"id":78923,"kind":"organization","name":"bluebird bio, Inc.","symbol":"BLUE"},"owners":[{"id":33771,"kind":"person","name":"Leiderman Elisabeth","position":1,"cik":"0001842133","reported_name":"Leiderman Elisabeth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-03T17:29:38.000Z","date":"2025-05-30","kind":"other","planned":false,"acquired":false,"shares":1112,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the terms of an Agreement and Plan of Merger, dated as of February 21, 2025 (as amended, the \"Merger Agreement\"), by and among the Issuer, Beacon Parent Holdings, L.P. (\"Parent\") and Beacon Merger Sub, Inc., an indirect wholly owned subsidiary of Parent (\"Purchaser\"), Purchaser completed a tender offer for shares of the Issuer's Common Stock. Tendering stockholders were given the option to receive per share consideration of either (x) $3.00 in cash per share, subject to any applicable withholding taxes and without interest thereon, plus one contingent value right (\"CVR\") per share, representing the right to receive one contingent payment of $6.84, in cash, subject to any applicable withholding taxes and without interest thereon, upon achievement of the specified milestone or (y) $5.00 in cash per share, subject to any applicable withholding taxes and without interest thereon (collectively, the \"Offer Price\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from footnote 1) After completion of the tender offer, Purchaser merged with and into the Issuer (the \"Merger\"), effective as of June 2, 2025 (the \"Effective Time\"), with the Issuer continuing as the surviving entity and a wholly owned subsidiary of Parent."}],"balance_after":1245,"source":{"system":"sec-edgar","filing":"0000950170-25-081135","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1293971/000095017025081135/ownership.xml","form_type":"4"}},{"id":1371230,"issuer":{"id":78923,"kind":"organization","name":"bluebird bio, Inc.","symbol":"BLUE"},"owners":[{"id":33771,"kind":"person","name":"Leiderman Elisabeth","position":1,"cik":"0001842133","reported_name":"Leiderman Elisabeth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-11-08T16:08:28.000Z","date":"2024-11-06","kind":"grant","planned":false,"acquired":true,"shares":49850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests 100% on the earlier of November 6, 2025 or the date of the next annual meeting of stockholders."}],"balance_after":49850,"derivative":{"exercise_price":0.44,"expiration_date":"2034-11-06","underlying":"Common Stock","underlying_shares":49850},"source":{"system":"sec-edgar","filing":"0001562180-24-007604","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1293971/000156218024007604/primarydocument.xml","form_type":"4"}},{"id":1371229,"issuer":{"id":78923,"kind":"organization","name":"bluebird bio, Inc.","symbol":"BLUE"},"owners":[{"id":33771,"kind":"person","name":"Leiderman Elisabeth","position":1,"cik":"0001842133","reported_name":"Leiderman Elisabeth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-08T16:08:28.000Z","date":"2024-11-06","kind":"grant","planned":false,"acquired":true,"shares":24900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These restricted stock units for common stock vest 100% on the earlier of November 6, 2025 or the date of the next annual meeting of stockholders."}],"balance_after":47156,"source":{"system":"sec-edgar","filing":"0001562180-24-007604","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1293971/000156218024007604/primarydocument.xml","form_type":"4"}},{"id":1849264,"issuer":{"id":78923,"kind":"organization","name":"bluebird bio, Inc.","symbol":"BLUE"},"owners":[{"id":33771,"kind":"person","name":"Leiderman Elisabeth","position":1,"cik":"0001842133","reported_name":"Leiderman Elisabeth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-20T16:30:58.000Z","date":"2023-06-16","kind":"grant","planned":false,"acquired":true,"shares":21600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests 100% on the earlier of June 16, 2024 or the date of the next annual meeting of stockholders."}],"balance_after":21600,"derivative":{"exercise_price":3.81,"expiration_date":"2033-06-16","underlying":"Common Stock","underlying_shares":21600},"source":{"system":"sec-edgar","filing":"0001562180-23-005351","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1293971/000156218023005351/primarydocument.xml","form_type":"4"}},{"id":1849263,"issuer":{"id":78923,"kind":"organization","name":"bluebird bio, Inc.","symbol":"BLUE"},"owners":[{"id":33771,"kind":"person","name":"Leiderman Elisabeth","position":1,"cik":"0001842133","reported_name":"Leiderman Elisabeth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-20T16:30:58.000Z","date":"2023-06-16","kind":"grant","planned":false,"acquired":true,"shares":10790,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These restricted stock units for common stock vest 100% on the earlier of June 16, 2024 or the date of the next annual meeting of stockholders."}],"balance_after":22256,"source":{"system":"sec-edgar","filing":"0001562180-23-005351","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1293971/000156218023005351/primarydocument.xml","form_type":"4"}},{"id":1960815,"issuer":{"id":78923,"kind":"organization","name":"bluebird bio, Inc.","symbol":"BLUE"},"owners":[{"id":33771,"kind":"person","name":"Leiderman Elisabeth","position":1,"cik":"0001842133","reported_name":"Leiderman Elisabeth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-09T16:06:33.000Z","date":"2022-10-17","kind":"sale","acquired":false,"shares":1004,"price":6.4643,"value":6490.1572,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were mistakenly sold to cover tax withholding obligations incurred in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The range in prices for the transaction reported on this line was $6.4614 to $6.4671. The average weighted price was $6.4643. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":11466,"source":{"system":"sec-edgar","filing":"0001562180-23-002662","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1293971/000156218023002662/primarydocument.xml","form_type":"4"}},{"id":2222931,"issuer":{"id":78923,"kind":"organization","name":"bluebird bio, Inc.","symbol":"BLUE"},"owners":[{"id":33771,"kind":"person","name":"Leiderman Elisabeth","position":1,"cik":"0001842133","reported_name":"Leiderman Elisabeth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-23T18:08:38.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests 100% on the earlier of June 22, 2023 or the date of the next annual meeting of stockholders."}],"balance_after":5000,"derivative":{"exercise_price":4.46,"expiration_date":"2032-06-22","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001562180-22-005336","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1293971/000156218022005336/primarydocument.xml","form_type":"4"}},{"id":2222930,"issuer":{"id":78923,"kind":"organization","name":"bluebird bio, Inc.","symbol":"BLUE"},"owners":[{"id":33771,"kind":"person","name":"Leiderman Elisabeth","position":1,"cik":"0001842133","reported_name":"Leiderman Elisabeth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-23T18:08:38.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":3109,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These restricted stock units for common stock vest 100% on the earlier of June 22, 2023 or the date of the next annual meeting of stockholders."}],"balance_after":12470,"source":{"system":"sec-edgar","filing":"0001562180-22-005336","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1293971/000156218022005336/primarydocument.xml","form_type":"4"}},{"id":2368299,"issuer":{"id":109458,"kind":"organization","name":"Decibel Therapeutics, Inc.","symbol":"DBTX"},"owners":[{"id":33771,"kind":"person","name":"Leiderman Elisabeth","position":1,"cik":"0001842133","reported_name":"Leiderman Elisabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (right to buy)","published_at":"2022-02-28T16:37:54.000Z","date":"2022-02-25","kind":"grant","acquired":true,"shares":52500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on February 25, 2022. The shares underlying the option are scheduled to vest with respect to 25% of the shares on February 25, 2023 and with respect to the remainder in 36 equal monthly installments thereafter through February 25, 2026."}],"balance_after":52500,"derivative":{"exercise_price":3.5,"expiration_date":"2032-02-24","underlying":"Common Stock","underlying_shares":52500},"source":{"system":"sec-edgar","filing":"0000899243-22-008087","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1656536/000089924322008087/doc4.xml","form_type":"4"}},{"id":2510359,"issuer":{"id":78923,"kind":"organization","name":"bluebird bio, Inc.","symbol":"BLUE"},"owners":[{"id":33771,"kind":"person","name":"Leiderman Elisabeth","position":1,"cik":"0001842133","reported_name":"Leiderman Elisabeth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-11-16T06:26:03.000Z","date":"2021-11-11","kind":"disposition_to_issuer","acquired":false,"shares":15057,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Represents options to purchase bluebird common stock awarded to the reporting person prior to the Separation. In connection with the Separation, the shares of common stock underlying this award were adjusted pursuant to the EMA to preserve the value associated with the original award (see footnotes 2 and 3). This option was originally granted on October 15, 2021 and shall vest over three years in annual installments commencing on October 15, 2021. The exercise price of the option has been adjusted based on the conversion ratio described in footnotes 2 and 3."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents options to purchase bluebird common stock awarded to the reporting person prior to the Separation. In connection with the Separation, the shares of common stock underlying this award were adjusted pursuant to the EMA to preserve the value associated with the original award (see footnotes 2 and 3). This option was originally granted on October 15, 2021 and shall vest over three years in annual installments commencing on October 15, 2021. The exercise price of the option has been adjusted based on the conversion ratio described in footnotes 2 and 3."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents options to purchase bluebird common stock awarded to the reporting person prior to the Separation. In connection with the Separation, the shares of common stock underlying this award were adjusted pursuant to the EMA to preserve the value associated with the original award (see footnotes 2 and 3). This option was originally granted on October 15, 2021 and shall vest over three years in annual installments commencing on October 15, 2021. The exercise price of the option has been adjusted based on the conversion ratio described in footnotes 2 and 3."}],"balance_after":15057,"derivative":{"exercise_price":10.41,"expiration_date":"2031-10-15","underlying":"Common Stock","underlying_shares":15057},"source":{"system":"sec-edgar","filing":"0001628280-21-023460","document":"wf-form4_163706189742341.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1293971/000162828021023460/wf-form4_163706189742341.xml","form_type":"4"}},{"id":2510358,"issuer":{"id":78923,"kind":"organization","name":"bluebird bio, Inc.","symbol":"BLUE"},"owners":[{"id":33771,"kind":"person","name":"Leiderman Elisabeth","position":1,"cik":"0001842133","reported_name":"Leiderman Elisabeth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-16T06:26:03.000Z","date":"2021-11-11","kind":"other","acquired":true,"shares":9361,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units awarded to the reporting person prior to the separation (the \"Separation\") of 2seventy bio, Inc. (\"2seventy\") from bluebird bio, Inc. (\"bluebird\"). In connection with the Separation, the restricted stock units underlying this award were adjusted pursuant to the the Employee Matters Agreement by and between 2seventy and bluebird (the \"EMA\") to preserve the value associated with the original restricted stock unit award (see footnotes 2 and 3). This restricted stock unit award was originally granted on October 15, 2021 and vests ratably over three years in annual installments commencing on October 15, 2021."},{"field":"security","element":"securityTitle","label":"F2","text":"bluebird equity awards granted prior to January 1, 2021 were converted into equity awards of both bluebird and 2seventy. The number of shares underlying the converted bluebird equity awards was determined by multiplying the number of shares underlying the existing bluebird equity award by a fraction, the numerator of which is the volume-weighted average trading price of bluebird common stock (trading \"regular way\") on the five trading days immediately prior to the distribution date (the \"bluebird Pre-Distribution VWAP\") and the denominator of which is the sum of (1) the volume-weighted average trading price of 2seventy common stock (trading \"regular way\") on the five trading days immediately following the distribution date multiplied by the distribution ratio and (2) the volume-weighted average trading price of bluebird bio common stock (trading \"regular way\") on the five trading days immediately following the distribution date (the \"bluebird Post-Distribution VWAP\")."},{"field":"security","element":"securityTitle","label":"F3","text":"bluebird equity awards granted on or after January 1, 2021, such equity awards continued as bluebird equity awards, subject to adjustment. The adjusted number of shares of bluebird common stock underlying such equity awards is equal to the number of shares of bluebird common stock subject to the equity award immediately prior to the distribution multiplied by a fraction, the numerator of which is the bluebird Pre-Distribution VWAP and the denominator of which is the bluebird Post-Distribution VWAP."}],"balance_after":9361,"source":{"system":"sec-edgar","filing":"0001628280-21-023460","document":"wf-form4_163706189742341.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1293971/000162828021023460/wf-form4_163706189742341.xml","form_type":"4"}},{"id":2539075,"issuer":{"id":78923,"kind":"organization","name":"bluebird bio, Inc.","symbol":"BLUE"},"owners":[{"id":33771,"kind":"person","name":"Leiderman Elisabeth","position":1,"cik":"0001842133","reported_name":"Leiderman Elisabeth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-10-19T20:00:43.000Z","date":"2021-10-15","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests ratably over three years in annual installments commencing on October 15, 2021."}],"balance_after":7500,"derivative":{"exercise_price":20.9,"expiration_date":"2031-10-15","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001562180-21-006578","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1293971/000156218021006578/primarydocument.xml","form_type":"4"}},{"id":2539074,"issuer":{"id":78923,"kind":"organization","name":"bluebird bio, Inc.","symbol":"BLUE"},"owners":[{"id":33771,"kind":"person","name":"Leiderman Elisabeth","position":1,"cik":"0001842133","reported_name":"Leiderman Elisabeth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-19T20:00:43.000Z","date":"2021-10-15","kind":"grant","acquired":true,"shares":4663,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These restricted stock units for common stock vest ratably over three years in annual installments commencing on October 15, 2021."}],"balance_after":4663,"source":{"system":"sec-edgar","filing":"0001562180-21-006578","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1293971/000156218021006578/primarydocument.xml","form_type":"4"}}]}